ARCHIVES

Biostatistician Thomas Fleming Warns Against Approval of Provenge.

This article is from The Cancer Letter archive.

Vol. 33 No. 17 | May 4, 2007

Download PDF Visit The Full Archive

Related Articles

CMS will pay oncologists to report adherence to practice guidelines.

November 4, 2005

In Brief: Ford Decides Against Asking For Recision Of NCI Funds After Congress Overrides Verto

October 8, 1976

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

In Brief: No More Shifts Planned For Treatment Programs; Groups Seek Surgeon, Radiologist Incentives

August 29, 1975

NCI Plans $61 Million For Six-Year Program In Biomarker Research For Early Detection

December 4, 1998

RRP Planning Dosimetry Center, Treatment Planning Projects

March 20, 1987